WELCOME TO CHARLES RUSSELL SPEECHLYS.
We would like to place strictly necessary cookies and performance cookies on your computer to improve our website service.
Otherwise, we'll assume you are OK to continue. Please close this message
Are you considering selling your pharmacy? In this article, we answer some common questions, to help sellers inform one of the biggest business decisions they will make.
Most buyers will try and ensure that they are the only horse in the race, and will ask the seller for a commitment not to negotiate with other prospective buyers for a period of time.
In return, a seller will often ask the buyer for a deposit of up to 10% of the agreed price. Usually the parties agree that the deposit can be refunded in certain circumstances (e.g. if the seller withdraws from the sale without fair reason).
Any buyer will also want to undertake due diligence into the pharmacy to confirm that the business conforms to their expectations and any sales information. It will also allow a buyer to understand what is required to operate the business from completion of the sale.
A due diligence exercise generally takes the form of questionnaires relating to all aspects of the operation of the pharmacy together with requests for certain documents. We therefore generally advise that a seller enter into a confidentiality agreement with the buyer before any sensitive information is shared with them.
If the pharmacy is sold by way of an asset sale then both parties must apply for NHS England change of ownership consent.
The consent can take time to obtain so it is generally recommended that the application be made as early as possible. Sellers should ensure they have contractual protection before submitting the application because once submitted, the buyer will have conduct of the application. If the pharmacy is sold by way of a share sale, such consent will not normally be needed.
Final transfer of the NHS contract takes place on the date on which NHS England updates its Pharmaceutical List.
It is important to ensure that the purchase completion date coincides with the date on which the Pharmaceutical List is amended – otherwise the buyer may not receive the NHS income accruing from the completion date and the seller will remain responsible for the pharmacy’s operation under the terms of the NHS Contract.
While a due diligence exercise should provide the buyer with a good level of knowledge about the business of the pharmacy, there is no statutory protection for a buyer in relation to any liabilities acquired. Sale contracts will therefore contain a number of contractual statements (so called “warranties”) as to the state of the business, covering areas such as employees, litigation, accounts accuracy, tax etc. which provides a buyer with the ability to make a claim against the seller if those statements prove to be incorrect.
Sellers will generally be able to negotiate some protection against warranty claims with the buyer. For example, they can agree a limited time period in which warranty claims can be made, a cap on the amount that can be claimed and also disclose any breach of the warranties occurring before the sale contract is signed.
This is often a point of negotiation between buyers and sellers. Buyers will generally not wish to subject their new investment to additional competition and so will often ask sellers to agree to enter into restrictions on having an interest in a competing pharmacy within a defined area for a period of time following the completion of the sale.
This article was written by Samuel Milne and was first published by P3 Pharmacy Magazine in September 2016.
For more information please contact Samuel on +44 (0)14 8325 2580 or email@example.com.